These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 36451519)
1. Response to letter regarding "inclusion of fibroblasts and collagen fibrils in the cytologic grading of canine cutaneous mast cell tumors". Paes PRO; Horta RS Vet Clin Pathol; 2022 Dec; 51(4):467. PubMed ID: 36451519 [No Abstract] [Full Text] [Related]
2. Inclusion of fibroblasts and collagen fibrils in the cytologic grading of canine cutaneous mast cell tumors. Krimer PM Vet Clin Pathol; 2022 Dec; 51(4):464-466. PubMed ID: 36451516 [No Abstract] [Full Text] [Related]
3. Inclusion of fibroblasts and collagen fibrils in the cytologic grading of canine cutaneous mast cell tumors. Paes PRO; Horta RS; Luza LC; Pierezan F; Costa MP; Lavalle GE Vet Clin Pathol; 2022 Sep; 51(3):339-348. PubMed ID: 35419864 [TBL] [Abstract][Full Text] [Related]
4. Use of a 2-tier histologic grading system for canine cutaneous mast cell tumors on cytology specimens. Hergt F; von Bomhard W; Kent MS; Hirschberger J Vet Clin Pathol; 2016 Sep; 45(3):477-83. PubMed ID: 27483044 [TBL] [Abstract][Full Text] [Related]
5. Reproducibility of nuclear morphometry parameters from cytologic smears of canine cutaneous mast cell tumors--intra- and interobserver variability. Barbosa Dde F; Paraventi MD; Strefezzi Rde F Vet Clin Pathol; 2014 Sep; 43(3):469-72. PubMed ID: 24976414 [TBL] [Abstract][Full Text] [Related]
7. Letter to the Editor re Hergt et al "Use of a 2-tier histologic grading system for canine cutaneous mast cell tumors on cytology specimens". Camus M; Priest H; Koehler J; Driskell E; Ilha M; Rakich P; Krimer P Vet Clin Pathol; 2016 Dec; 45(4):531. PubMed ID: 27716984 [No Abstract] [Full Text] [Related]
8. Clinical, pathologic, and molecular characterization of a non-metastatic multicentric cutaneous mast cell tumor in a cow. Chevallier L; Briand A; Reyes-Gomez E; Defer W; Millemann Y; Béguin J Vet Clin Pathol; 2024 Mar; 53(1):131-135. PubMed ID: 38418393 [TBL] [Abstract][Full Text] [Related]
10. Canine mast cell tumors: utility of stereologic tools in cytology. Marcos R; Almeida J; Marques J; Moreira R; Dias-Pereira P; Correia-Gomes C; Santos M J Vet Diagn Invest; 2022 Mar; 34(2):263-267. PubMed ID: 34763591 [TBL] [Abstract][Full Text] [Related]
11. Utility of flow cytometry in canine primary cutaneous and matched nodal mast cell tumor. Sulce M; Marconato L; Martano M; Iussich S; Dentini A; Melega M; Miniscalco B; Riondato F Vet J; 2018 Dec; 242():15-23. PubMed ID: 30503539 [TBL] [Abstract][Full Text] [Related]
12. [The contribution of pathology in the clinical diagnosis of cutaneous mast cell tumors in the dog]. van Garderen E; Vos JH; Meertens NM; Peperkamp NH; Junker K; de Vos JP Tijdschr Diergeneeskd; 2012 Jan; 137(1):30-7. PubMed ID: 22372055 [No Abstract] [Full Text] [Related]
13. Expression of proto-oncogene C-kit and correlation with morphological evaluations in canine cutaneous mast cell tumors. Passantino L; Passantino G; Cianciotta A; Ribaud MR; Lo Presti G; Ranieri G; Perillo A Immunopharmacol Immunotoxicol; 2008; 30(3):609-21. PubMed ID: 18608529 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of immunohistochemical markers in canine cutaneous mast cell tumours: A systematic review and meta-analysis. Freytag JO; Queiroz MR; Govoni VM; Pereira IVA; Pulz LH; de Francisco Strefezzi R; Queiroga FL; Cogliati B Vet Comp Oncol; 2021 Sep; 19(3):529-540. PubMed ID: 33724647 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of tissue inhibitor of metalloproteinase-1 correlates with improved outcome in canine cutaneous mast cell tumours. Pulz LH; Barra CN; Kleeb SR; Xavier JG; Catão-Dias JL; Sobral RA; Fukumasu H; Strefezzi RF Vet Comp Oncol; 2017 Jun; 15(2):606-614. PubMed ID: 27041588 [TBL] [Abstract][Full Text] [Related]
16. Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two-grade malignancy classification. Śmiech A; Ślaska B; Łopuszyński W; Jasik A; Bochyńska D; Dąbrowski R Acta Vet Scand; 2018 Nov; 60(1):70. PubMed ID: 30390687 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of intralesional triamcinolone administration for treatment of mast cell tumors in dogs: 23 cases (2005-2011). Case A; Burgess K J Am Vet Med Assoc; 2018 Jan; 252(1):84-91. PubMed ID: 29244608 [TBL] [Abstract][Full Text] [Related]
18. 18FDG-PET imaging in canine lymphoma and cutaneous mast cell tumor. LeBlanc AK; Jakoby BW; Townsend DW; Daniel GB Vet Radiol Ultrasound; 2009; 50(2):215-23. PubMed ID: 19400472 [TBL] [Abstract][Full Text] [Related]
19. High-Grade Cutaneous Mast Cell Tumour with Widespread Intrathoracic Metastasis and Neoplastic Pericardial Effusion in a Dog. Yale AD; Szladovits B; Stell AJ; Fitzgerald SD; Priestnall SL; Suarez-Bonnet A J Comp Pathol; 2020 Oct; 180():29-34. PubMed ID: 33222871 [TBL] [Abstract][Full Text] [Related]
20. Ex vivo evaluation of imatinib mesylate for induction of cell death on canine neoplastic mast cells with mutations in c-Kit exon 11 via apoptosis. Rossi G; Bertani C; Mari S; Marini C; Renzoni G; Ogilvie G; Magi GE Vet Res Commun; 2013 Jun; 37(2):101-8. PubMed ID: 23315207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]